Enhanced Group, Inc. — Second Quarter 2026 Earnings Summary

Financial Performance

• Reported revenue of $17.7 million for the three months ended June 30, 2026, compared to $0 in the prior-year period, primarily driven by sponsorship revenue from the inaugural Enhanced Games.
• Reported a net loss of $61.9 million for the quarter, compared to a net loss of $3.0 million in the prior-year period.
• Reported an adjusted EBITDA loss of $42.7 million for the quarter, compared to a loss of $2.7 million in the prior-year period.
• Cash and cash equivalents totaled $19.6 million as of June 30, 2026, a decrease from $25.3 million as of December 31, 2025.
• Cash used in operating activities was $44.0 million for the six months ended June 30, 2026, compared to $7.5 million in the prior-year six-month period.
• Loss from operations was $61.9 million for the quarter, compared to $3.0 million in the prior-year period.
• Operating expenses for the quarter included $52.0 million in games, athletes, and event operating costs, $16.6 million in selling, general and administrative expenses, and $10.9 million in transaction expenses.

Guidance and Future Outlook

• Management expects the remaining sponsorship revenue associated with the approximately $32 million of aggregate sponsorship deal value to be recognized in future periods as performance obligations are satisfied.
• The company plans to expand its model beyond one tentpole event per year with the Enhanced Breakers Series to sustain audience engagement and sponsor interest year-round.
• Management anticipates regulatory tailwinds in the peptide space to develop, which they believe will distinguish legitimate, medically supervised operators from the unregulated gray market.
• The company is evaluating strategic M&A opportunities and partnerships to accelerate capabilities in sports, live entertainment, and consumer businesses.

Business Segments and Product Lines

• The company operates as a single reportable segment within an integrated sports, entertainment, and consumer-health ecosystem.
• Launched the Live Enhanced platform, featuring an athlete-branded protocol stack and a product line including 11 Rx therapies and two proprietary supplement products.
• Secured 10 sponsors for the inaugural Enhanced Games with a total sponsorship contract value of $32 million.
• Signed an exclusive media rights agreement with Roku to deliver the Games to 100 million North American households.
• Successfully completed the interventional phase of a first-of-its-kind Institutional Review Board (IRB)-approved clinical trial.
• Debuted the Enhanced Breakers event series, which operates at a fraction of the cost of a full Games event.

Market and Competitive Landscape

• The inaugural Enhanced Games engaged one billion people globally, including four million live views (excluding Roku streaming data).
• Independent media coverage generated 4,000 global stories reaching a combined 16.7 billion unique visitors per month, with an additional ~932 million people watching via broadcast television.
• Brand research indicated 61% of respondents were aware of the Enhanced Games pre-event, with 67% holding a positive view; post-event assessments positioned the property alongside Hyrox and The CrossFit Games based on consumer brand strength.
• The company reported significant growth in owned audience (+884%), social engagements (+419%), and video views (+227%) during the event period.

Risks and Challenges

• The company faces risks related to its limited operating history, history of operating losses, and the need for additional capital and financing.
• Future profitability depends on the ability to stage future events profitably and secure sponsorship, media rights, ticketing, and hospitality revenue on anticipated terms.
• The business is subject to risks regarding changes in laws and regulations applicable to performance-enhancing substances, peptides, compounded products, and telehealth.
• Potential risks include adverse publicity, litigation, or regulatory action concerning the company, its events, products, or key personnel.
• The company faces competition in the telehealth, supplement, and performance medicine markets, including pricing pressure.

Management Commentary and Tone

• CEO Maximilian Martin stated the company has transitioned from a privately held startup to a globally recognized sports brand and the only organization to successfully conduct a medically supervised enhanced sporting event in history.
• Management described the Q2 results as reflecting an intentional decision to invest heavily in the inaugural Games as a foundational platform and customer acquisition engine for the performance medicine business.
• Management expressed confidence in the company's ability to capitalize on societal developments in sports and live entertainment in an increasingly AI-driven world.
• The company views the developing regulatory framework for peptides as a potential tailwind that distinguishes legitimate operators from the unregulated market.

Other Key Points

• Following the success of the Games, the company raised $50 million in a PIPE financing, including participation from the Executive Chairman and CEO.
• As of the release date, $3.3 million from tranche two of the PIPE financing was received, with $13.3 million from tranche three expected to be received on or about August 14, 2026.
• The company submitted written testimony to the U.S. Food and Drug Administration's Peptide Coalition Advisory Committee in July 2026.
• Athletes achieved 21 personal bests and three world records since the inception of the program.
• A one-hour ESPN E:60 documentary aired on the Enhanced Games on July 2nd.
• The company is strengthening its United States supply chain and pharmacy partnerships to support personalized compounding and nationwide fulfillment.